Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Fornaro

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Rheumatology International|July 8, 2026
Assessment of CDASI scoring by a multimodal large language model: a comparative study with expert assessorsMarco Fornaro, Vincenzo Venerito, Swapnasha Panigrahi, et al.
Journal of Neurology|May 30, 2025
Peripheral neuropathies associated with anti-tnf-α treatments: a systematic review and proposed recommendationsGiammarco Milella, Marco Sozzo, Piergiorgio Lasorella, et al.
Dermatologic Therapy|July 23, 2020
Effectiveness and safety of secukinumab in patients with moderate-severe psoriasis: A multicenter real-life studyAntonio Carpentieri, Paola Mascia, Marco Fornaro, et al.
Journal of Clinical Medicine|August 10, 2024
Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK InhibitorsAndrea Cito, Marco Fornaro, Angela Carenza, et al.
European Journal of Clinical Investigation|August 7, 2018
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settingsFlorenzo Iannone, Fausto Salaffi, Marco Fornaro, et al.
RMD Open|January 6, 2022
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitorsVincenzo Venerito, Pasquale Stefanizzi, Marco Fornaro, et al.
Clinical and Experimental Immunology|August 6, 2021
Body mass index and adipokines/cytokines dysregulation in systemic sclerosisFlorenzo Iannone, Emanuela Praino, Cinzia Rotondo, et al.
Clinical and Experimental Rheumatology|November 28, 2022
Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitorsVincenzo Venerito, Pasquale Stefanizzi, Andrea Martinelli, et al.
Mediators of Inflammation|November 9, 2018
Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab TreatmentFabio Cacciapaglia, Maria Grazia Anelli, Angela Rinaldi, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 4, 2021
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis PatientsFabio Cacciapaglia, Simone Perniola, Vincenzo Venerito, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Rheumatology International|July 8, 2026
Assessment of CDASI scoring by a multimodal large language model: a comparative study with expert assessorsMarco Fornaro, Vincenzo Venerito, Swapnasha Panigrahi, et al.
Journal of Neurology|May 30, 2025
Peripheral neuropathies associated with anti-tnf-α treatments: a systematic review and proposed recommendationsGiammarco Milella, Marco Sozzo, Piergiorgio Lasorella, et al.
Dermatologic Therapy|July 23, 2020
Effectiveness and safety of secukinumab in patients with moderate-severe psoriasis: A multicenter real-life studyAntonio Carpentieri, Paola Mascia, Marco Fornaro, et al.
Journal of Clinical Medicine|August 10, 2024
Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK InhibitorsAndrea Cito, Marco Fornaro, Angela Carenza, et al.
European Journal of Clinical Investigation|August 7, 2018
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settingsFlorenzo Iannone, Fausto Salaffi, Marco Fornaro, et al.
RMD Open|January 6, 2022
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitorsVincenzo Venerito, Pasquale Stefanizzi, Marco Fornaro, et al.
Clinical and Experimental Immunology|August 6, 2021
Body mass index and adipokines/cytokines dysregulation in systemic sclerosisFlorenzo Iannone, Emanuela Praino, Cinzia Rotondo, et al.
Clinical and Experimental Rheumatology|November 28, 2022
Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitorsVincenzo Venerito, Pasquale Stefanizzi, Andrea Martinelli, et al.
Mediators of Inflammation|November 9, 2018
Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab TreatmentFabio Cacciapaglia, Maria Grazia Anelli, Angela Rinaldi, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 4, 2021
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis PatientsFabio Cacciapaglia, Simone Perniola, Vincenzo Venerito, et al.
Pageof 8